Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD112R compositions and methods

Anti-CD112R compositions and methods

US Patent 11214619 · Granted Jan 4, 2022

Estimated economic value: $3,402,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human PD-L2 antibodies and methods of use therefor2025
Human PD-L2 antibodies and methods of use therefor2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Anti-IL-27 antibodies and uses thereof2025
CD38 modulating antibody agents2025
Human PD-L1 antibodies and methods of use therefor2025
Human PD-L1 antibodies and methods of use therefor2025
CD38 modulating antibody2025
RGMC-selective inhibitors and use thereof2025
RGMC-selective inhibitors and use thereof2025